🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,931 results for “The” Clear

  1. Pioglitazone 15mg

    United Therapeutics Europe Ltd

    High Altitude

    approved small molecule completed

    1 trial

  2. Pioglitazone then Placebo

    Takeda

    Diabetes

    approved small molecule completed

    1 trial

  3. Placebo of rosuvastatin 10mg (tablet) as produced by Apotheek A15, Rosuvastatin tablet 10mg Apotheek A15

    Disc Medicine

    Statin-intolerance, High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)

    approved small molecule active

    1 trial

  4. Placebo suspension is identical to Symbioflor®2 liquid formulation in appearance, weight and composition, with the exception that the active ingredient will be omitted. Placebo constitutes are sodium chloride, magnesium sulphate 7H2O, potassium chloride, calcium chloride 2H2O, magnesium chloride 6H2O, and purified water, Symbioflor 2 Tropfen zum Einnehmen, Suspension

    Alphapharm Pty Ltd

    Irritable Bowel Syndrome

    approved small molecule active

    1 trial

  5. Placebo used in this trial is a foodgrade, redried potato starch. It is a white powder with bland taste and free from objectionable odours. Insoluble in water with a temperature below 50 °C and most organic solvents, solution is slightly hazy. The product is intended for use in food., POTATO STARCH, SODIUM CHLORIDE, AMILORIDE

    Disc Medicine

    Autosomal Dominant Polycystic Kidney Disease

    approved small molecule active

    1 trial

  6. Plasma rich in growth factors, -

    The George Institute

    Glaucoma, Dry eye disease

    approved small molecule active

    1 trial

  7. Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución, Hidrathea 9 mg/ml colirio en solución

    Wuhan Createrna Science and Technology Co., Ltd

    Dry Eye Disease

    approved small molecule active

    1 trial

  8. Plavix 75 mg film-coated tablets, CARDIOASPIRIN 100 mg Compresse gastroresistenti, CARDIOASPIRIN 100 mg Compresse gastroresistenti, Plavix 300 mg film-coated tablets

    Fondazione Telethon ETS

    Patients with atrial fibrillation undergoing percutaneous left atrial appendage closure with the Amulet device

    approved small molecule active

    1 trial

  9. Pramipexole

    The First People's Hospital of Lianyungang

    Restless Legs Syndrome

    approved small molecule terminated

    1 trial

  10. Prednisolone

    United Therapeutics Europe Ltd

    COPD Exacerbation

    approved small molecule completed

    1 trial

  11. Prednisona Pensa 5 mg comprimidos EFG, Simulect 20 mg powder for solution for injection or infusion, tacrolimus cinfa 1 mg cápsulas duras EFG, Micofenolato Mofetile Accord 250 mg capsule rigide, Metilprednisolona NORMON 40 mg polvo y disolvente para solución inyectable EFG, TIMOGLOBULINA 5 mg/ml, polvo para solución para perfusión

    The George Institute

    Kidney Transplant

    approved small molecule active

    1 trial

  12. Prednisone Mylan Pharma 5 mg compresse, Prednisone Mylan Pharma 5 mg compresse

    Sana Biotechnology

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial

  13. Pregabalin

    Vera Therapeutics

    Pain, Postoperative

    approved small molecule completed

    1 trial

  14. Prevenar 13

    United Therapeutics Europe Ltd

    Sepsis

    approved mab completed

    1 trial

  15. Prilocaine (Hyperbaric 2%)

    United Therapeutics Europe Ltd

    Cervical Incompetence in Pregnancy as Antepartum Condition

    approved small molecule active

    1 trial

  16. Programming (CRT-D, ICD OptiVol® and Cardiac Compass® )

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other terminated

    1 trial

  17. Prothrombin Complex Concentrate, Human

    The First People's Hospital of Lianyungang

    Cardiac Surgical Procedures

    approved small molecule active

    1 trial

  18. RF Ablation procedure

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    approved other completed

    1 trial

  19. RIBOCICLIB, Kisqali 200 mg film-coated tablets

    The George Institute

    Hormone receptor–positive (HRpos)/human epidermal growth factor receptor 2–negative (HER2neg) early breast cancer at risk of recurrence

    approved small molecule active

    1 trial

  20. RITALINE L.P. 10 mg, gélule à libération prolongée

    Tour Hekla

    Attention Deficit Disorder with or without Hyperactivity (ADHD) is a neurodevelopmental disorder characterized by disabling symptoms of inattention and/or hyperactivity-impulsivity beginning before the age of 12 with significant personal, social, academic and/or occupational impact (American Psychiatric Association 2013). This disorder, whose prevalence is around 5% in children and adolescents, affects 2.6% of adults (American Psychiatric Association 2013; Song et al. 2021).

    approved small molecule active

    1 trial

  21. RIVAROXABAN , RIVAROXABAN, RIVAROXABAN

    Pari Pharma GmbH

    Patients with excessive supraventricular ectopies or short atrial runs (ESVEA) defined as ≥ 1% premature atrial contractions (PAC) /24 hours or any atrial runs ≥ 20 PACs (but shorter than 30 seconds) on a 24-hour Holter ECG monitoring and CHA2DS2VASC score ≥ 3. Patients with any atrial runs ≥ 20 PACs but shorter than 30 seconds on a 15-21 days Holter ECG monitoring and CHA2DS2VASC score ≥ 3 may also be included in the Short-Run trial.

    approved small molecule active

    1 trial

  22. ROSUVASTATIN AND EZETIMIBE , BEMPEDOIC ACID , ROSUVASTATIN AND EZETIMIBE , ATORVASTATIN AND AMLODIPINE

    The George Institute

    CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoriatic arthritis or axial spondyloarthritis or systemic lupus erythematosus

    approved small molecule active

    1 trial

  23. Rabipur Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze Tollwut-Impfstoff (inaktiviert), RABIPUR, poudre et solvant pour solution injectable en seringue préremplie. Vaccin rabique (inactivé)., Rabipur poeder en oplosmiddel voor oplossing voor injectie in een voorgevulde spuit.Rabiësvaccin (geïnactiveerd).

    The George Institute

    rabies pre-exposure prophylaxis

    approved small molecule active

    1 trial

  24. Raltitrexed

    The First People's Hospital of Lianyungang

    Head and Neck Squamous Cell Carcinoma

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources